Bioelectronics Corp (BIEL)

[art2426]

>>>especially if CanCapital called in that non-convertible $140,000 loan that matured on 12/17/2022.<<<

Yeah, I would sure like to know how that maturity was handled. Did they get an extension? Because in the balance sheet, there certainly was not enough $$$ to pay loan off. Many times loaner will extend loan if at least interest is paid. This should all be disclosed in financials next quarter but not holding my breath for it to happen. But this particular loan, though very substantial, is only a small fraction of what is coming due in 2023 when it comes to note loans that convert to 50% discounted priced stock. Where are they going to get the money or shares to accommodate all those maturing notes, especially with the authorized shares about maxed out? So many red flags!